Future Health ESG Corp.
FHLT
NASDAQ Capital Market10.96
USD
-0.64
- -
Future Health ESG Corp.
FHLT
(NASDAQ Capital Market)
Recent
price
10.96
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Future Health ESG Corp. (FHLT) operates as a blank check company, or special purpose acquisition company (SPAC), whose primary purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities, with a historical focus on value-based precision healthcare opportunities. Incorporated in 2021 and headquartered in Dover, Delaware, the company currently maintains no significant ongoing operations or core products and services beyond pursuing such a transaction. In recent developments, it terminated a planned business combination with AI technology platform Excelera announced in June 2022; underwent a sponsor handover to Blufire Capital Limited in March 2024, appointing Jesvin Kaur as CEO and director while former management including Bradley A. Bostic resigned; secured a non-redemption agreement for 800,000 shares alongside a deadline extension to December 31, 2024, despite some redemptions leaving approximately $10 million in trust; and received $1 million in funding in January 2024. The company trades on the Nasdaq with a minimal market capitalization and negative earnings per share, reflecting its pre-transaction status, and its website now aligns with Blufire Capital's advisory services in corporate restructuring, capital markets, and corporate advisory across energy and finance sectors from Abu Dhabi.
Company News
Excelera to Become Publicly Traded via Merger with Future Health (NASDAQ: FHLT)